FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 312:611-617 March 7, 1985 Number 10 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

We studied a new hereditary syndrome of hypophosphatemic rickets and hypercalciuria in six affected members of one kindred. In all patients, the manifestations of disease began in early childhood. The characteristic features are rickets, short stature, increased renal phosphate clearance (the ratio between the maximal tubular reabsorption rate for phosphorus and the glomerular filtration rate [TmP/GFR] is 2 to 4 S.D. below the age-related mean), hypercalciuria (8.6 mg of urinary calcium per kilogram of body weight per 24 hours vs. the upper normal value of 4.0), normal serum calcium levels, increased gastrointestinal absorption of calcium and phosphorus, an elevated serum concentration of 1,25-dihydroxyvitamin D (390 +/- 99 pg per milliliter vs. the upper normal value of 110), and suppressed parathyroid function (an immunoreactive parathyroid hormone level of 0.33 +/- 0.1 ng per milliliter and a cyclic AMP level of 1.39 +/- 0.12 nmol per deciliter of glomerular filtrate vs. the lower normal values of 0.3 and 1.5, respectively). Long-term phosphate supplementation as the sole therapy resulted in reversal of all clinical and biochemical abnormalities except the decreased TmP/GFR. We propose that the pivotal defect in this syndrome is a renal phosphate leak resulting in hypophosphatemia with an appropriate elevation of 1,25-dihydroxyvitamin D levels, which causes increased calcium absorption, parathyroid suppression, and hypercalciuria. This syndrome may represent one end of a spectrum of hereditary absorptive hypercalciuria. Our observations support the importance of phosphate as a mediator in controlling 1,25-dihydroxyvitamin D production in human beings.

This article has been cited by other articles:

• Iwaki, T., Sandoval-Cooper, M. J., Tenenhouse, H. S., Castellino, F. J. (2008). A Missense Mutation in the Sodium Phosphate Co-transporter Slc34a1 Impairs Phosphate Homeostasis. J. Am. Soc. Nephrol. 19: 1753-1762 [Abstract] [Full Text]  
• Jaureguiberry, G., Carpenter, T. O., Forman, S., Juppner, H., Bergwitz, C. (2008). A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc. Am. J. Physiol. Renal Physiol. 295: F371-F379 [Abstract] [Full Text]  
• Razzaque, M. S, Lanske, B. (2007). The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol 194: 1-10 [Abstract] [Full Text]  
• Segawa, H., Yamanaka, S., Onitsuka, A., Tomoe, Y., Kuwahata, M., Ito, M., Taketani, Y., Miyamoto, K.-i. (2007). Parathyroid hormone-dependent endocytosis of renal type IIc Na-Pi cotransporter. Am. J. Physiol. Renal Physiol. 292: F395-F403 [Abstract] [Full Text]  
• Ichikawa, S., Sorenson, A. H., Imel, E. A., Friedman, N. E., Gertner, J. M., Econs, M. J. (2006). Intronic Deletions in the SLC34A3 Gene Cause Hereditary Hypophosphatemic Rickets with Hypercalciuria. J. Clin. Endocrinol. Metab. 91: 4022-4027 [Abstract] [Full Text]  
• Jan de Beur, S. M. (2005). Tumor-Induced Osteomalacia. JAMA 294: 1260-1267 [Abstract] [Full Text]  
• Moe, O. W., Bonny, O. (2005). Genetic Hypercalciuria. J. Am. Soc. Nephrol. 16: 729-745 [Abstract] [Full Text]  
• Tenenhouse, H. S., Murer, H. (2003). Disorders of Renal Tubular Phosphate Transport. J. Am. Soc. Nephrol. 14: 240-247 [Full Text]  
• Prie, D., Huart, V., Bakouh, N., Planelles, G., Dellis, O., Gerard, B., Hulin, P., Benque-Blanchet, F., Silve, C., Grandchamp, B., Friedlander, G. (2002). Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium-Phosphate Cotransporter. NEJM 347: 983-991 [Abstract] [Full Text]  
• Jan De Beur, S. M., Levine, M. A. (2002). Molecular Pathogenesis of Hypophosphatemic Rickets. J. Clin. Endocrinol. Metab. 87: 2467-2473 [Full Text]  
• Tenenhouse, H. S., Martel, J., Gauthier, C., Zhang, M. Y. H., Portale, A. A. (2001). Renal Expression of the Sodium/Phosphate Cotransporter Gene, Npt2, Is Not Required for Regulation of Renal 1{{alpha}}-Hydroxylase by Phosphate. Endocrinology 142: 1124-1129 [Abstract] [Full Text]  
• JONES, A. O., TZENOVA, J., FRAPPIER, D., CRUMLEY, M. J., ROSLIN, N. M., KOS, C. H., TIEDER, M., LANGMAN, C. B., PROESMANS, W., CARPENTER, T. O., RICE, A., ANDERSON, D., MORGAN, K., FUJIWARA, T. M., TENENHOUSE, H. S. (2001). Hereditary Hypophosphatemic Rickets with Hypercalciuria Is Not Caused by Mutations in the Na/Pi Cotransporter NPT2 Gene. J. Am. Soc. Nephrol. 12: 507-514 [Abstract] [Full Text]  
• Murer, H., Hernando, N., Forster, I., Biber, J. (2000). Proximal Tubular Phosphate Reabsorption: Molecular Mechanisms. Physiol. Rev. 80: 1373-1409 [Abstract] [Full Text]  
• Reed, B. Y., Heller, H. J., Gitomer, W. L., Pak, C. Y. C. (1999). Mapping a Gene Defect in Absorptive Hypercalciuria to Chromosome 1q23.3-q24. J. Clin. Endocrinol. Metab. 84: 3907-3913 [Abstract] [Full Text]  
• Scheinman, S. J., Guay-Woodford, L. M., Thakker, R. V., Warnock, D. G. (1999). Genetic Disorders of Renal Electrolyte Transport. NEJM 340: 1177-1187 [Full Text]  
• Beck, L., Karaplis, A. C., Amizuka, N., Hewson, A. S., Ozawa, H., Tenenhouse, H. S. (1998). Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. Proc. Natl. Acad. Sci. USA 95: 5372-5377 [Abstract] [Full Text]  
• Econs, M. J., McEnery, P. T. (1997). Autosomal Dominant Hypophosphatemic Rickets/Osteomalacia: Clinical Characterization of a Novel Renal Phosphate-Wasting Disorder. J. Clin. Endocrinol. Metab. 82: 674-681 [Abstract] [Full Text]